The $630 figure reflects a review of more than a dozen current, individually attributed price targets rather than any single website's headline number. The range is unusually wide, from Barclays' cautious Sell initiation near $430 to a high around $815, which underscores how much disagreement exists beneath the "Buy"-leaning consensus.
Bullish analysts emphasize visibility into multi-year programs. NOC drew an upgrade from Baird to Outperform with a $675 target after its Q3 "beat and raise," while Morgan Stanley previously named the stock a top defense pick with a $745 target. Citi ($667), Susquehanna ($655), and Rothschild & Co Redburn ($680) also hold targets near or above the mean. On the cautious side, Goldman Sachs trimmed its target to $525, TD Cowen to $540, and RBC Capital downgraded to Hold with a $525 target, reflecting concerns about valuation and program-execution risk. The mean of these views, roughly $632, rounds to the $630 central target used throughout this article. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
NOC closed near $551.44, giving a required upside of approximately 14% to reach $630 — a modest move by equity-market standards. The stock has climbed roughly 9% in the week following its third-quarter report, though it remains well below its 52-week high near $774.
The path toward $630 depends largely on whether the company sustains its improved operating momentum. Northrop reported Q3 revenue of $11.1 billion, up 7% year over year, with diluted EPS of $7.89. Management raised 2026 segment operating income guidance to $4.94 billion–$5.04 billion and lifted its mark-to-market-adjusted EPS outlook to $29.35–$29.75, while projecting 5%–7% sales growth in 2027.
A record backlog — reported around $110 billion, well over twice annual revenue — provides multi-year demand visibility across aeronautics, defense systems, mission systems, and space. The B-21 Raider bomber and the Sentinel intercontinental ballistic missile program are central to the bull case, along with international and munitions demand. Consistent "beat and raise" quarters, improving segment margins, and favorable positioning within U.S. and allied defense budgets could justify higher valuations and support further target revisions upward.
The principal obstacle is execution and policy risk. Northrop carries meaningful fixed-price and development programs, where unfavorable estimate-at-completion adjustments — such as those tied to the GEM 63XL and SAW programs — have pressured margins. Defense budgets are inherently political, and any slowdown in appropriations could compress growth expectations. A large charge on the B-21 program, elevated capital spending, or valuation compression from rising rates would all weigh against the stock approaching $630.
NOC's 52-week range of roughly $470 to $774 frames the technical picture. The $550 area has functioned as a near-term pivot following the post-earnings advance, while the prior high near $774 stands as the most significant overhead resistance. The $630 target sits roughly mid-range between these levels, well below the prior peak, suggesting the stock would not need to break its all-time high to reach it.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms differ in their methodologies and time frames. Investors should watch upcoming quarterly results, revisions to segment-margin and EPS guidance, contract awards and backlog trends, U.S. defense budget and appropriations developments, and any updates on B-21 and Sentinel milestones. Sustained analyst target increases — or a reversal toward downgrades — will be the clearest signal of which direction the consensus is moving. From what I see, tracking these elements with tools like Tickeron’s AI Trend Prediction Engine can add useful context.
Can NOC reach $630? The average analyst price target implies roughly 14% upside from current levels, but the path is not assured. The bull case rests on a record backlog, raised guidance, and multi-decade defense programs, while the bear case centers on budget uncertainty and fixed-price execution risk. The unusually wide $430-to-$815 range shows that even professional forecasters disagree sharply on valuation. A move toward $630 would likely require continued margin expansion and constructive defense-budget news, while further cost overruns or a spending slowdown could keep the stock below its average target.
In my own research process, Tickeron's AI Daily Buy/Sell Signals have proven helpful for monitoring names like NOC. The tool uses artificial intelligence to scan thousands of stocks and ETFs in real time, surfacing Buy, Sell, or Hold signals based on technical shifts and market conditions. It offers a practical way to complement manual analysis when tracking defense stocks or broader opportunities.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
NOC moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 38 of 51 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on NOC as a result. In 40 of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 56%.
The Moving Average Convergence Divergence (MACD) for NOC just turned positive on October 14, 2026. Looking at past instances where NOC's MACD turned positive, the stock continued to rise in 22 of 45 cases over the following month. The odds of a continued upward trend are 49%.
Following a +3.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where NOC advanced for three days, in 196 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
NOC broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NOC entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. NOC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 54 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.380) is normal, around the industry mean (4.788). P/E Ratio (17.495) is within average values for comparable stocks, (16.638). Projected Growth (PEG Ratio) (3.350) is also within normal values, averaging (2.564). Dividend Yield (0.018) settles around the average of (0.060) among similar stocks. P/S Ratio (1.766) is also within normal values, averaging (18.330).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of innovative systems, products and solutions in aerospace, electronics and information systems
Industry AerospaceDefense